✦ LIBER ✦

A novel peptide nanomedicine for treatment of pancreatogenic diabetes

✍ Scribed by Banerjee, Amrita; Onyuksel, Hayat

Book ID: 118278182
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 464 KB
Volume: 9
Category: Article
ISSN: 1549-9634
DOI: 10.1016/j.nano.2012.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Case report of a novel percutaneous tran

Case report of a novel percutaneous transhepatic treatment of a pancreatogenic bile duct stricture.

✍ Huszár, Orsolya; Szíjártó, Attila; Tihanyi, Tibor; Harsányi, László; Szücs, Ákos 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 50 KB

A novel liposomal nanomedicine for nitri

A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment

✍ Lee, Soo Yeon ;Rim, Yonghoon ;McPherson, David D. ;Huang, Shao-Ling ;Kim, Hyungg 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 1014 KB

Novel peptide therapeutics for treatment

Novel peptide therapeutics for treatment of infections

✍ Oyston, P. C. F.; Fox, M. A.; Richards, S. J.; Clark, G. C. 📂 Article 📅 2009 🏛 Society for General Microbiology 🌐 English ⚖ 210 KB

Computational Evaluation of a Prospectiv

Computational Evaluation of a Prospective Antimicrobial Peptide for Application in Nanomedicine

✍ Sethumadhavan, Rao; Rajasekaran, R. 📂 Article 📅 2009 🏛 American Scientific Publishers 🌐 English ⚖ 221 KB

SGLT2 inhibition — a novel strategy for

SGLT2 inhibition — a novel strategy for diabetes treatment

✍ Chao, Edward C.; Henry, Robert R. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 587 KB

Peptide drug delivery strategies for the

Peptide drug delivery strategies for the treatment of diabetes

✍ Negar Sadrzadeh; Michael J. Glembourtt; Cynthia L. Stevenson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 1 views

Drug delivery strategies for diabetes have included a wide range of scientific and engineering approaches, including molecular design, formulation and device design. Molecular engineering has resulted in modified pharmacokinetics, such as rapid-acting or slow-release analogs of insulin. Long-acting